Clinical Trial Update: The Mutation Profile and Prognosis in AML With IDH1/2 Mutation

View source ↗

Summary

Clinical trial update on mutation profile and prognosis for acute myeloid leukemia patients with IDH1/2 mutations; the study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: AML | Status: TERMINATED